220 related articles for article (PubMed ID: 22450391)
21. [Current therapy with TNFalpha blocking agents for ankylosing spondylitis and undifferentiated spondyloarthritis].
Brandt J; Sieper J; Braun J
Z Rheumatol; 2004 Jun; 63(3):203-10. PubMed ID: 15224223
[TBL] [Abstract][Full Text] [Related]
22. Biological therapies in the spondyloarthritides--the current state.
Braun J; Sieper J
Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
[TBL] [Abstract][Full Text] [Related]
23. [Disease-modifying anti-rheumatic drugs for treatment of ankylosing spondylitis].
Madsen OR; Egsmose C
Ugeskr Laeger; 2009 Aug; 171(33):2268-72. PubMed ID: 19732504
[TBL] [Abstract][Full Text] [Related]
24. Update of the literature review on treatment with biologics as a basis for the first update of the ASAS/EULAR management recommendations of ankylosing spondylitis.
Baraliakos X; van den Berg R; Braun J; van der Heijde D
Rheumatology (Oxford); 2012 Aug; 51(8):1378-87. PubMed ID: 22427410
[TBL] [Abstract][Full Text] [Related]
25. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
Gorman JD; Sack KE; Davis JC
N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
[TBL] [Abstract][Full Text] [Related]
26. Emerging drugs for the treatment of axial and peripheral spondyloarthritis.
Braun J; Kiltz U; Heldmann F; Baraliakos X
Expert Opin Emerg Drugs; 2015 Mar; 20(1):1-14. PubMed ID: 25575936
[TBL] [Abstract][Full Text] [Related]
27. New evidence on the management of spondyloarthritis.
Sieper J; Poddubnyy D
Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
[TBL] [Abstract][Full Text] [Related]
28. Baseline predictors of response to TNF-α blocking therapy in ankylosing spondylitis.
Arends S; van der Veer E; Kallenberg CG; Brouwer E; Spoorenberg A
Curr Opin Rheumatol; 2012 May; 24(3):290-8. PubMed ID: 22418743
[TBL] [Abstract][Full Text] [Related]
29. Are there new emerging drugs for ankylosing spondylitis or spondyloarthritis?
Wendling D
Expert Opin Emerg Drugs; 2013 Mar; 18(1):5-7. PubMed ID: 23216081
[TBL] [Abstract][Full Text] [Related]
30. Current therapeutics for spondyloarthritis.
Toussirot É
Expert Opin Pharmacother; 2011 Nov; 12(16):2469-77. PubMed ID: 21988214
[TBL] [Abstract][Full Text] [Related]
31. Etanercept: new indication. For ankylosing spondylitis: another option.
Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
[TBL] [Abstract][Full Text] [Related]
32. Anti-TNF-alpha therapy in ankylosing spondylitis.
De Keyser F; Van den Bosch F; Mielants H
Cytokine; 2006 Mar; 33(5):294-8. PubMed ID: 16516484
[TBL] [Abstract][Full Text] [Related]
33. Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial.
Wei JC; Chan TW; Lin HS; Huang F; Chou CT
J Rheumatol; 2003 Dec; 30(12):2627-31. PubMed ID: 14719205
[TBL] [Abstract][Full Text] [Related]
34. Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent.
AlDhaheri F; Almteri T; Dwid N; Majdali A; Janoudi N; Almoallim H
Am J Case Rep; 2017 Feb; 18():143-147. PubMed ID: 28179619
[TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
[TBL] [Abstract][Full Text] [Related]
36. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.
Akkoc N; van der Linden S; Khan MA
Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):539-57. PubMed ID: 16777581
[TBL] [Abstract][Full Text] [Related]
37. Spondyloarthritis: update on pathogenesis and management.
Reveille JD; Arnett FC
Am J Med; 2005 Jun; 118(6):592-603. PubMed ID: 15922688
[TBL] [Abstract][Full Text] [Related]
38. TNF inhibitors for ankylosing spondylitis in the real world.
McVeigh CM; Bell AL; Cairns AP
Rheumatol Int; 2007 Dec; 28(2):199-200. PubMed ID: 17602229
[No Abstract] [Full Text] [Related]
39. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.
Keat A; Barkham N; Bhalla A; Gaffney K; Marzo-Ortega H; Paul S; Rogers F; Somerville M; Sturrock R; Wordsworth P;
Rheumatology (Oxford); 2005 Jul; 44(7):939-47. PubMed ID: 15901904
[No Abstract] [Full Text] [Related]
40. BSR guidelines for TNF blockers in ankylosing spondylitis--how useful are they?
Sheehy C; Murphy E; Barry M
Rheumatology (Oxford); 2006 Sep; 45(9):1176-7; author reply 1177-8. PubMed ID: 16820380
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
